1. Home
  2. WST vs LII Comparison

WST vs LII Comparison

Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • LII
  • Stock Information
  • Founded
  • WST 1923
  • LII 1895
  • Country
  • WST United States
  • LII United States
  • Employees
  • WST N/A
  • LII N/A
  • Industry
  • WST Medical/Dental Instruments
  • LII Industrial Machinery/Components
  • Sector
  • WST Health Care
  • LII Industrials
  • Exchange
  • WST Nasdaq
  • LII Nasdaq
  • Market Cap
  • WST 23.2B
  • LII 21.7B
  • IPO Year
  • WST N/A
  • LII 1999
  • Fundamental
  • Price
  • WST $325.68
  • LII $667.13
  • Analyst Decision
  • WST Buy
  • LII Buy
  • Analyst Count
  • WST 3
  • LII 14
  • Target Price
  • WST $460.33
  • LII $577.08
  • AVG Volume (30 Days)
  • WST 587.4K
  • LII 257.4K
  • Earning Date
  • WST 10-24-2024
  • LII 10-23-2024
  • Dividend Yield
  • WST 0.26%
  • LII 0.69%
  • EPS Growth
  • WST N/A
  • LII 38.78
  • EPS
  • WST 6.74
  • LII 21.04
  • Revenue
  • WST $2,876,400,000.00
  • LII $5,151,100,000.00
  • Revenue This Year
  • WST N/A
  • LII $5.80
  • Revenue Next Year
  • WST $6.22
  • LII $7.02
  • P/E Ratio
  • WST $48.32
  • LII $31.70
  • Revenue Growth
  • WST N/A
  • LII 4.68
  • 52 Week Low
  • WST $265.00
  • LII $405.65
  • 52 Week High
  • WST $413.70
  • LII $682.50
  • Technical
  • Relative Strength Index (RSI)
  • WST 55.88
  • LII 65.24
  • Support Level
  • WST $315.17
  • LII $655.44
  • Resistance Level
  • WST $325.00
  • LII $682.50
  • Average True Range (ATR)
  • WST 9.97
  • LII 14.11
  • MACD
  • WST -0.48
  • LII 4.29
  • Stochastic Oscillator
  • WST 54.64
  • LII 79.34

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About LII Lennox International Inc.

Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2023, residential HVAC was 68% of sales and commercial HVAC and Heatcraft refrigeration was 32% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.

Share on Social Networks: